These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2508850)

  • 21. Lymphoblastoid interferon therapy of chronic HBV infection. A comparison of 12 vs. 24 weeks of thrice weekly treatment.
    Scully LJ; Shein R; Karayiannis P; McDonald JA; Thomas HC
    J Hepatol; 1987 Aug; 5(1):51-8. PubMed ID: 3655310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
    Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
    Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon alfa therapy in patients with chronic hepatitis B virus infection. Effects on hepatitis B virus DNA in the liver.
    Lok AS; Ma OC; Lau JY
    Gastroenterology; 1991 Mar; 100(3):756-61. PubMed ID: 1993497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
    Gregorio GV; Jara P; Hierro L; Diaz C; de la Vega A; Vegnente A; Iorio R; Bortolotti F; Crivellaro C; Zancan L; Daniels H; Portmann B; Mieli-Vergani G
    Hepatology; 1996 Apr; 23(4):700-7. PubMed ID: 8666320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon alfa treatment of chronic hepatitis B: randomized trial in a predominantly homosexual male population.
    Wong DK; Yim C; Naylor CD; Chen E; Sherman M; Vas S; Wanless IR; Read S; Li H; Heathcote EJ
    Gastroenterology; 1995 Jan; 108(1):165-71. PubMed ID: 7806038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
    Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
    Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
    Garcia G; Smith CI; Weissberg JI; Eisenberg M; Bissett J; Nair PV; Mastre B; Rosno S; Roskamp D; Waterman K
    Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study.
    Realdi G; Fattovich G; Pastore G; Caredda F; Noventa F; Santantonio T; Moroni M; Criscuolo D; Maladorno D; Rugge M
    J Hepatol; 1990; 11 Suppl 1():S129-32. PubMed ID: 2079570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
    Keeffe EB; Hollinger FB
    Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
    Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
    Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-alpha therapy with and without interferon-alpha priming in patients with chronic hepatitis B infection.
    Catterall AP; King R; Lau JY; Daniels HM; Alexander GJ; Murray-Lyon IM; Williams R
    J Antimicrob Chemother; 1993 May; 31(5):777-82. PubMed ID: 8335505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy.
    Lampertico P; Del Ninno E; Viganò M; Romeo R; Donato MF; Sablon E; Morabito A; Colombo M
    Hepatology; 2003 Apr; 37(4):756-63. PubMed ID: 12668967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up.
    Perez V; Findor J; Tanno H; Sordá J
    Gut; 1993; 34(2 Suppl):S91-4. PubMed ID: 8314497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
    Bourlière M; Rabiega P; Ganne-Carrie N; Serfaty L; Marcellin P; Barthe Y; Thabut D; Guyader D; Hezode C; Picon M; Causse X; Leroy V; Bronowicki JP; Carrieri P; Riachi G; Rosa I; Attali P; Molina JM; Bacq Y; Tran A; Grangé JD; Zoulim F; Fontaine H; Alric L; Bertucci I; Bouvier-Alias M; Carrat F;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):177-188. PubMed ID: 28404133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.
    Anderson MG; Harrison TJ; Alexander G; Zuckerman AJ; Murray-Lyon IM
    Gut; 1987 May; 28(5):619-22. PubMed ID: 3297940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of a randomized trial of interferon therapy for chronic hepatitis B in a predominantly homosexual male population.
    Chen DK; Yim C; O'Rourke K; Krajden M; Wong DK; Heathcote EJ
    J Hepatol; 1999 Apr; 30(4):557-63. PubMed ID: 10207795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.
    Ruiz Moreno M; Jimenez J; Porres JC; Bartolomé J; Moreno A; Carreño V
    Digestion; 1990; 45(1):26-33. PubMed ID: 2187723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.